Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Simple Urine Home Test Kit Could Detect Early-Stage Breast Cancer

By LabMedica International staff writers
Posted on 25 Mar 2026

Breast cancer is the most commonly diagnosed cancer among women globally and remains a leading cause of cancer-related deaths in more than 100 countries. More...

Current diagnostic pathways rely on mammography, magnetic resonance imaging (MRI), and biopsy, which can be invasive or difficult to access. There is growing interest in noninvasive tools that detect early disease using easily collected specimens. Researchers now report progress toward a urine-based lateral flow approach intended to flag early biochemical signatures of breast cancer.

At Aberystwyth University (Aberystwyth, Wales, UK), scientists are developing a simple, noninvasive home test kit in the form of a prototype lateral flow device—similar to a pregnancy or COVID-19 test—that detects early biochemical signs of breast cancer from a single urine sample. The initiative targets early detection to support faster diagnosis and reduce dependence on invasive procedures. The concept aims to provide an accessible format suitable for use outside clinical settings.

The approach focuses on metabolic changes associated with breast cancer that are excreted in urine. By identifying a distinct biochemical signature, the device is intended to provide an indication of early-stage disease. The research team is translating laboratory findings into a point-of-need format using lateral flow technology to enable straightforward readouts.

The work forms part of a new clinical research program at Aberystwyth University that links biomarker discovery to prototype development. The group is collaborating with National Health Service colleagues to accelerate movement from proof-of-concept to practical tools. The project is supported through the Welsh Government’s SMART Award program and co-sponsored by Dynamic Extractions Ltd, whose separation-technology expertise complements the university’s analytical and clinical capabilities.

In addition to breast cancer, the team is exploring urine-based diagnostics for endometriosis and polycystic ovary syndrome (PCOS) to help address diagnostic delays in women’s health. The translational pathway is designed to shorten the interval between discovery, validation, and real-world deployment, in partnership with health boards.

“Our work is revealing a distinct biochemical ‘signature’ associated with the earliest stages of breast cancer—one that can be detected in a simple urine sample. By translating these findings into a lateral flow test, we hope to create a diagnostic tool that is affordable, easy to use at home, and capable of detecting cancer earlier than many current methods. Early diagnosis saves lives, and our aim is to make that crucial first step accessible to as many women as possible,” said Professor Luis Mur, who leads the research at Aberystwyth University.

Related Links
Aberystwyth University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.